AVR vs EXAS · rev $1.9M vs rev $2.76B
Anteris Technologies Global Corp. Common Stock (AVR) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Anteris Technologies Global Corp. Common Stock (AVR) is a medical instruments & supplies company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported AVR revenue for 2025-12-31 was $1.9M. Net income was -$94.1M. Revenue was down 29.2% from 2024-12-31 to 2025-12-31. AVR currently screens at market cap $287.2M.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
AVR currently screens at market cap $287.2M. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the AVR and EXAS stock pages for the full models.
Not investment advice.